ARTICLE | Company News
Introgen other research news
January 29, 2001 8:00 AM UTC
INGN received a $238,000 SBIR grant from the National Cancer Institute to evaluate an adenoviral vector that carries the apoptosis-inducing mda-7 gene for use in lung cancer. INGN 241 is in Phase I tr...